Fundraising Fox

Clade Therapeutics

Cambridge, US · Founded 2020 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

LV
Leandro VetcherExecutive Officer
DV
Daniel VasellaDirector
JG
Jim GlasheenExecutive Officer, Director
NW
Neil WhiteDirector
CA
Chad A. CowanExecutive Officer, Director
MM
Martin MurphyDirector

Investors · 1

SynconaLondon

Reported raises · per SEC filings

Form D private placements
▶$42KraisedJan 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Leandro VetcherExecutive Officer
Offering amount
$66K
Amount sold
$42K
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.9MraisedNov 2021 · 31 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Leandro VetcherExecutive Officer
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
Offering amount
$87.1M
Amount sold
$45.9M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.